Candidiasis

Olive leaf is the one candidiasis herb with a human trial. A 2025 randomised controlled trial found the extract beneficial as an adjunct to standard antifungal therapy in Candida-related oral disease ^{1Reference 1Kinkela Devčić et al. · 2025RCTBeneficial effect of olive leaf extract as an adjunct to standard antifungal therapy in treating Candida-related oral diseases — randomised controlled trialView study →}. It was added to an antifungal, not used instead of one, and applied in the mouth, where it touches the lesion directly.

The laboratory data are weak. Minimum inhibitory concentrations against C. albicans and C. dubliniensis run to tens of milligrams per millilitre ^{2Reference 2Zorić et al. · 2016In vitroOlive leaf extract activity against Candida albicans and C. dubliniensis — in vitro viability studyView study →}, too high for a systemic effect from oral dosing to be likely.

Olive leaf phenolics also potentiate ampicillin against bacteria ^{3Reference 3Lim et al. · 2016In vitroPlant phenols as antibiotic boosters: in vitro interaction of olive leaf phenols with ampicillin — in vitroView study →}, which points to a wider role alongside antimicrobial drugs.

Proanthocyanidin polymeric tannins from barbatimão bark inhibited both free-floating and biofilm cells of C. albicans and non-albicans species — including fluconazole-resistant isolates. A topical gel reduced fungal burden in mice with vaginal candidiasis ^{4Reference 4de Freitas et al. · 2018In vitroProanthocyanidin polymeric tannins from Stryphnodendron adstringens are effective against Candida spp. isolates and for vaginal candidiasis treatment — in vitro and mouse modelView study →}, the only animal confirmation among the antifungal herbs.

The gel worked against resistant strains and against biofilm, in a topical form close to how the bark is traditionally used. There is no human trial, and the tested material was a purified tannin fraction, not a bark decoction.

Usnea acts on Candida’s virulence rather than its growth. Usnic acid inhibited C. albicans biofilm formation by around 65%, blocked the yeast-to-hypha switch, thinned mature biofilms and reduced the exopolysaccharide matrix ^{5Reference 5Nithyanand et al. · 2015In vitroUsnic acid inhibits biofilm formation and virulent morphological traits of Candida albicans — in vitroView study →}; it is also active against C. orthopsilosis and C. parapsilosis ^{6Reference 6Pires et al. · 2012In vitroEffect of usnic acid on Candida orthopsilosis and C. parapsilosis — in vitroView study →}. Hyphal switching and biofilm are the two things that make Candida pathogenic and drug-tolerant, so they make a better target than simple killing. None of this has yet been tested in an animal or a person.

The liver injuries on record involved isolated usnic acid concentrated into weight-loss products, not the traditional tincture or wash of the whole lichen — a dose and a preparation apart. Usnea’s antifungal use is topical, which is also where the tradition sits.

Oregano oil is the most popular “natural antifungal”, and its laboratory record is consistent. A PRISMA systematic review of Origanum essential oils found O. vulgare the best-studied species with reliable activity against Candida and other pathogenic fungi ^{7Reference 7Mezzomo et al. · 2025Systematic reviewOriganum essential oil and antifungal activity — systematic reviewView study →}, and mechanistic work shows the oil and carvacrol suppress Malassezia virulence factors ^{8Reference 8Angiolella et al. · 2023In vitroModulatory effect of Origanum vulgare essential oil and carvacrol on Malassezia spp. virulence factors — in vitroView study →}. There are no controlled human trials of oral oregano for candidiasis, and the antifungal concentrations exceed anything achievable from dietary or normal supplemental intake. Oregano oil is taken diluted — undiluted essential oil is an irritant to mucous membranes, as most concentrated volatile oils are.

Candida is pau d’arco’s best-known folk application — taheebo tea taken for three to four weeks — and the in-vitro data are consistent: Tabebuia extracts inhibit C. albicans and multiple non-albicans species, plus Cryptococcus, Aspergillus and dermatophytes ^{9,10,11Reference 9Portillo et al. · 2001In vitroAntifungal activity of Paraguayan plants used in traditional medicine — in vitroView study →Reference 10Silva et al. · 2009In vitroEvaluation of the antifungal potential of Brazilian Cerrado medicinal plants — in vitroView study →Reference 11Höfling et al. · 2010In vitroAntimicrobial potential of some plant extracts against Candida species — in vitroView study →}. But there is no human trial at all.

The activity also tracks the naphthoquinones, which a simple water infusion may extract poorly, so even the traditional tea may not deliver the active fraction. The toxicity data that circulate for pau d’arco come from isolated lapachol given at pharmacological doses, not from the bark decoction.

Black seed has genuine human antimicrobial evidence — but it is for Helicobacter pylori, not Candida. Its antifungal activity, against Candida and dermatophytes, is documented mainly in vitro and has no controlled clinical confirmation ^{12Reference 12Gholamnezhad et al. · 2016ReviewPreclinical and clinical effects of Nigella sativa and its constituent thymoquinone — reviewView study →}.

A phytochemical survey of S. glabra rhizome isolated 63 phenolic compounds and found activity against gram-positive bacteria and C. albicans ^{13Reference 13Xu et al. · 2013In vitroChemical constituents from the rhizomes of Smilax glabra and their antimicrobial activity — in vitroView study →}. This is an incidental finding inside a broad antimicrobial screen rather than a dedicated antifungal investigation, and there is no in-vivo confirmation. Sarsaparilla’s better-supported directions lie elsewhere.

Traditionally used across Amazonia for fungal infections and “Candida overgrowth”, usually alongside its main urinary indications. The measured antifungal data do not cover Candida: the best work is on the fresh xylem sap and its constituent fisetin against the Cryptococcus neoformans complex and dermatophytes ^{14Reference 14da Costa et al. · 2014In vitroAntifungal and cytotoxicity activities of the fresh xylem sap of Hymenaea courbaril L. and its major constituent fisetin — in vitroView study →} — different organisms, and a different plant part from the bark that is traditionally sold. The Candida claim rests on tradition alone.